FDA Investigator Aurora Miha Trifanov
Aurora Miha Trifanov has conducted inspections on 6 sites in 2 countries as of 08 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
08 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Canada
FDA Investigators that have inspected at least one site in common with Aurora Miha Trifanov:
Alan M Barker,
Alan M Roberts,
Amanda E Lewin, PhD,
Andrea F White,
Anita Narula, PhD,
Ann L Demarco,
Ann Raju Daniel,
Art O Czabaniuk,
Azza Talaat,
Barbara D Wright,
Bei Y He,
Brenda W Uratani, PhD,
Brian L Belz,
Camerson E Moore,
Carla J Lundi,
Carmen M Faraianu,
Caroline H Le,
Charanjeet Jassal,
Charisse K Green,
Charles L Zhou,
Charles M Edwards,
Daniel J Brown,
Daniel J Grabicki,
Diane L Raccasi,
Djamila Harouaka,
Eileen A Liu,
Emilie E Kahn,
Emily J Orban,
Francis A Guidry,
Hala L Selby,
Israel Santiago, OCM,
Jacob G Lutz,
James A Jagon,
Jeffrey D Meng,
Joseph A Piechocki,
Karen M Cooper,
Katherine Szestypalow,
Kathryn E Ogger,
Kristy A Zielny,
Kristy E Zuroski,
L'oreal D Fowlkes,
L'oreal F Walker,
Laureen F Kononen,
Laurimer Kuilan Torres,
Li Hongpaul Yeh, PhD,
Lloyd D Payne,
Margaret M Annes,
Maria C Iuga,
Marian E Ramirez,
Mark R Mcclain,
Matthew B Casale,
Matthew C Watson,
Miah I Schneider,
Michael R Goga,
Michele L Forster, PhD,
Monica E Caphart,
Nicholas F Lyons,
Parul M Patel,
Patsy J Domingo,
Paul A Bonneau,
Prabhu P Raju,
Rebecca E Dombrowski,
Regina T Brown,
Reginald Walker,
Renee L Rice, PhD,
Richard W Thornton,
Robert M Barbosa,
Roger A Hartman,
Russell K Riley,
S Lori Brown, PhD MPH,
Sanket N Patel,
Sarah E Mcmullen,
Sarah M Meng,
Sarah M Napier,
Sharon K Thoma, PharmD,
Shirshendu K Deb, PhD,
Steven M Weinman,
Susanne M Richardson, MS RAC,
Thomas J Arista,
Tina M Pawlowski,
Tracey L Siebesma,
Tracey L Taylor,
Truong Xuan Nguyen (Andy),
Walden H Lee,
Xikui Chen (nmi), PhD,
Yiying E Chen
Aurora Miha Trifanov's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2013 | FDA 483 | Sun Pharmaceutical Industries, Inc. - Form 483, 2013-05-30 |
June, 2016 | EIR | Element Materials Technology Ann Arbor LLC - EIR, 2016-06-28 |
November, 2016 | FDA 483 | King Pharmaceuticals LLC - Form 483, 2016-11-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more